Insider · CIK 0001705477

Nofi Michael

Reports to the SEC for 3 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001705477

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+24.4K sh	—	—	24,375
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+48.8K sh	—	—	48,750
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+48.8K sh	—	—	48,750
2025-11-10	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+43.8K sh	—	—	43,750
2025-11-10	EWTXEdgewise Therapeutics, Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+263K sh	—	—	262,500
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−30.6K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Performance Share UnitsD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−8,661 sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−78.3K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−65K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−40K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−20.2K sh	—	—	0
2025-01-10	SpringWorks Therapeutics, Inc.A Award	Chief Accounting Officer	AAward	+6,929 sh	—	—	30,623
2025-01-10	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+20.2K sh	—	—	20,246
2025-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−1,009 sh	$38.86	−$39.2K	23,694
2025-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−1,636 sh	$38.19	−$62.5K	24,703
2025-01-04	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−2,388 sh	$38.19	−$91.2K	26,339
2024-01-08	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−1,063 sh	$41.53	−$44.1K	28,727
2024-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−1,169 sh	$37.96	−$44.4K	29,790
2024-01-04	SpringWorks Therapeutics, Inc.A Award	Chief Accounting Officer	AAward	+14.1K sh	—	—	30,959
2024-01-04	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+40K sh	—	—	40,000
2023-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−409 sh	$26.41	−$10.8K	16,855
2023-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−783 sh	$27.52	−$21.5K	17,264
2023-01-05	SpringWorks Therapeutics, Inc.A Award	Chief Accounting Officer	AAward	+9,713 sh	—	—	18,047
2023-01-05	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+30K sh	—	—	30,000
2023-01-05	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+35K sh	—	—	35,000
2022-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−414 sh	$56.06	−$23.2K	8,334
2022-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−567 sh	$56.06	−$31.8K	8,181
2022-01-06	SpringWorks Therapeutics, Inc.A Award	Chief Accounting Officer	AAward	+5,748 sh	—	—	8,748
2022-01-06	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+17.9K sh	—	—	17,913
2021-01-07	SpringWorks Therapeutics, Inc.A Award	Chief Accounting Officer	AAward	+3,000 sh	—	—	3,000
2021-01-07	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+24K sh	—	—	24,000
2019-12-02	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Accounting Officer	AAward	+78.3K sh	—	—	78,300

Recent filings

Accepted (ET)
Aug 174/A
Nofi Michael0001705477-26-000002
SEC(opens sec.gov)
Aug 144
Nofi Michael0001705477-26-000001
SEC(opens sec.gov)
Nov 134
Nofi Michael0001705477-25-000005
SEC(opens sec.gov)
Jul 24
Nofi Michael0001104659-25-065302
SEC(opens sec.gov)
Jan 144
Nofi Michael0001104659-25-003466
SEC(opens sec.gov)
Jan 74
Nofi Michael0001104659-25-001773
SEC(opens sec.gov)
Jan 84
Nofi Michael0001104659-24-002376
SEC(opens sec.gov)

Companies

Address

1715 38TH STREET

BOULDER, CO, 80301